| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |